These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2109418)

  • 1. Studies of host immunomodulation and prevention of pancreatic beta cell destruction.
    Brayman KL; Naji A; Barker CF
    Transplant Proc; 1990 Apr; 22(2):851-2. PubMed ID: 2109418
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.
    Bartlett ST; Schweitzer EJ; Kuo PC; Johnson LB; Delatorre A; Hadley GA
    Transplantation; 1997 Jan; 63(2):299-303. PubMed ID: 9020334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful islet transplantation in BB rats without chronic immunosuppression.
    Chabot JA; Lau H; Reemtsma K; Hardy MA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):974-5. PubMed ID: 3152652
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation.
    Markees TG; Appel MC; Noelle RJ; Mordes JP; Greiner DL; Rossini AA
    Transplant Proc; 1996 Apr; 28(2):814-5. PubMed ID: 8623413
    [No Abstract]   [Full Text] [Related]  

  • 5. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
    Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
    Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolongation of islet allografts by pretreatment with intrathymic UV-B donor spleen cells.
    Jin MX; Chowdhury NC; James T; Engelstad K; Hardy MA; Oluwole SF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):291. PubMed ID: 8438304
    [No Abstract]   [Full Text] [Related]  

  • 7. No correlation between changes in lymphocyte subsets and pancreatic B cell destruction.
    Kuttler B; Heym S; Volk HD; Diamantstein T; Hahn HJ
    Horm Metab Res Suppl; 1990; 25():182-7. PubMed ID: 2088964
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity.
    Schröder D; Wanka H; Hehmke B; Klöting I; Köhler E; Knospe S; Schmidt S
    Diabetes Res; 1990 Sep; 15(1):27-32. PubMed ID: 2132197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a combined antigen-cyclosporine regimen in four transplantation models.
    Didlake R; Kakazaki K; Yoshimura N; Merrell R; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1281-3. PubMed ID: 3152626
    [No Abstract]   [Full Text] [Related]  

  • 10. Nature of tolerance induction to peripheral (extrathymic) islet allografts.
    Coulombe M; Lafferty KJ; Gill RG
    Transplant Proc; 1994 Apr; 26(2):720-1. PubMed ID: 8171624
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of unresponsiveness to islet allograft by preoperative donor spleen cell injection and FK 506 treatment.
    Fukuzaki T; Gotoh M; Monden M; Dono K; Wada H; Kita Y; Kanai T; Mori T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):975. PubMed ID: 7680173
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of transplant site on islet allograft survival in BB rats.
    Woehrle MF; Markmann JF; Armstrong J; Naji A
    Transplant Proc; 1987 Feb; 19(1 Pt 2):925-7. PubMed ID: 3152638
    [No Abstract]   [Full Text] [Related]  

  • 13. A composite graft of islet plus donor lymph node cells induced donor specific tolerance in a "low responder" rat combination with class I MHC disparity.
    Maeda A; Ito T; Yumiba T; Ohkawa A; Uchikoshi F; Tori M; Sawai T; Nozawa M; Matsuda H
    Transplant Proc; 1999; 31(1-2):749-50. PubMed ID: 10083320
    [No Abstract]   [Full Text] [Related]  

  • 14. Allotransplantation of neonatal islets in nonimmunosuppressed normal and diabetic rats.
    Serie JR; Hegre OD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):962-4. PubMed ID: 3152649
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of host immunomodulation on the prevention of islet allograft primary nonfunction in a murine model.
    Kaufman DB; Rabe FL; Platt JL; Dunn DL; Sutherland DE
    Transplant Proc; 1990 Apr; 22(2):857-8. PubMed ID: 2109421
    [No Abstract]   [Full Text] [Related]  

  • 16. Temporary anti-CD-25 treatment results in tolerance development in syngeneically grafted autoimmune diabetic recipients.
    Hahn HJ; Kuttler B; Dunger A; Lucke S; Volk HD; Diamantstein T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):741-2. PubMed ID: 1990673
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of rapamycin on islet and skin xenograft survival.
    Bobbio SA; Porter JG; Monaco AP
    Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.
    Jeyarajah DR; Schmeisser FS; Josephson MA; Sohn DG; Thistlethwaite JR
    Transplant Proc; 1994 Apr; 26(2):771-3. PubMed ID: 8171656
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic consequences of islet MHC antigen modulation in autoimmune diabetes.
    Markmann JF; Posselt AM; Levy M; Naji A; Barker CF
    Transplant Proc; 1990 Apr; 22(2):849-50. PubMed ID: 2109417
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of autoimmune damage to islet grafts in BB rats by antibody therapy.
    Markmann JF; Jacobson J; Kimura H; Brayman KL; Barker CF; Naji A
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2703-4. PubMed ID: 2495674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.